| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |